Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Lexaria Corp. (Lexaria Bioscience Corp.) on May 27, 2009, covering events occurring on May 25, 2009. The company is incorporated in Nevada with its principal address in Vancouver, British Columbia, Canada.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event and contains no financial statements or performance data.
Material Changes
The material change reported is the departure of a senior executive. On May 25, 2009, Mr. Leonard MacMillan resigned from his positions as Vice President and Director of the Company.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the executive departure.
Key Facts for Investors to Verify
- Confirmation of Mr. Leonard MacMillan's resignation as Vice President and Director effective May 25, 2009.
- Whether a successor has been appointed to fill the vacant Director seat.
- The impact of this departure on the company's ongoing operations and strategic direction.